Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Physalis peruviana extract is more effective in treating benign prostatic hyperplasia in rats than finasteride and terazosine.

There is no link between hair loss and prostate enlargement.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

People with early-onset hair loss (AGA) have a higher risk of heart disease, metabolic syndrome, and prostate enlargement.

Gene variation affects prostate issues and hair loss.

% free PSA and urinary markers help better identify prostate cancer.

Men with benign prostate hyperplasia have more meibomian gland loss and tear film problems.

BPH treatments are improving with personalized medicine and better surgical options.

Prostate surgery is often effective long-term, but some patients may need more treatment or another surgery, especially if they had prostatitis before.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Treatments for enlarged prostate can cause problems with ejaculation, and less invasive options might preserve sexual function better.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

The role of 5α-reductase-3 in prostate cancer is unclear and needs more research.

Finasteride effectively reduces prostate size and lowers surgery risk in men with benign prostatic hyperplasia.

Finasteride is effective for hair loss and may help prevent prostate cancer without increasing high-grade cancer risk.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

Finasteride effectively reduces DHT and E2 levels, helping with prostate enlargement.

5α-reductase inhibitors help manage symptoms of benign prostatic hyperplasia and may also prevent prostate cancer and treat hair loss.

Doctors should adjust how they treat men with prostate-related urinary problems during and after the COVID-19 pandemic.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

The treatment improved prostate health in mice.

Combining doxazosin and finasteride is more effective for managing benign prostatic hyperplasia than using either drug alone.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Metabolic syndrome worsens treatment outcomes for urinary symptoms in men with enlarged prostate.

Combining α-blockers with 5α-reductase inhibitors improves symptoms and outcomes for severe benign prostatic hyperplasia.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Certain drugs that block specific enzymes can help treat prostate diseases.